Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Capital Southwest
CSWC
$1.61B
| $545K | ﹤0.01% |
24,717
-128,753
| -84% | -$2.65M |
|
3652
Distribution Solutions Group
DSGR
$1.61B
| $544K | ﹤0.01% |
19,815
+6,543
| +49% | +$175K |
|
|
GBFH
3653
GBank Financial Holdings
GBFH
$315M
| $544K | ﹤0.01% |
+15,349
| New | +$601K |
|
3654
Solid Power
SLDP
$545M
| $542K | ﹤0.01% |
247,364
+91,622
| +59% | +$129K |
|
3655
RCI Hospitality Holdings
RICK
$230M
| $541K | ﹤0.01% |
14,181
+5,508
| +64% | +$222K |
|
3656
Target Hospitality
TH
$1.62B
| $540K | ﹤0.01% |
75,900
+17,895
| +31% | +$124K |
|
3657
PUT
Mobileye
MBLY
$7.57B
| $539K | ﹤0.01% |
+30,000
| New | +$458K |
|
3658
Voyager Therapeutics
VYGR
$198M
| $534K | ﹤0.01% |
171,831
+60,783
| +55% | +$196K |
|
|
BCAX
3659
Bicara Therapeutics
BCAX
$1.56B
| $533K | ﹤0.01% |
57,334
+37,063
| +183% | +$442K |
|
3660
Red River Bancshares
RRBI
$681M
| $532K | ﹤0.01% |
9,068
+4,450
| +96% | +$241K |
|
3661
Waterstone Financial
WSBF
$385M
| $532K | ﹤0.01% |
38,530
+19,377
| +101% | +$248K |
|
3662
Occidental Petroleum Corp Warrants
OXY.WS
$33.7B
| $531K | ﹤0.01% |
25,624
-2,626
| -9% | -$54.3K |
|
3663
Northeast Community Bancorp
NECB
$371M
| $527K | ﹤0.01% |
22,673
+7,593
| +50% | +$172K |
|
|
ARDT
3664
Ardent Health
ARDT
$1.55B
| $526K | ﹤0.01% |
38,520
-902
| -2% | -$12.1K |
|
3665
Lightspeed Commerce
LSPD
$1.42B
| $525K | ﹤0.01% |
44,867
-873
| -2% | -$8.99K |
|
3666
Quanterix
QTRX
$135M
| $525K | ﹤0.01% |
78,980
+24,119
| +44% | +$134K |
|
3667
Foster
FSTR
$404M
| $523K | ﹤0.01% |
23,913
+8,137
| +52% | +$159K |
|
3668
Acco Brands
ACCO
$399M
| $523K | ﹤0.01% |
146,082
+26,704
| +22% | +$98.7K |
|
|
UBFO
3669
DELISTED
United Security Bancshares
UBFO
| $523K | ﹤0.01% |
60,456
+26,445
| +78% | +$226K |
|
3670
Pulse Biosciences
PLSE
$3.2B
| $523K | ﹤0.01% |
34,648
+7,834
| +29% | +$130K |
|
3671
CALL
CSX Corp
CSX
$92.9B
| $522K | ﹤0.01% |
+16,000
| New | +$481K |
|
3672
PUT
Vulcan Materials
VMC
$36B
| $522K | ﹤0.01% |
2,000
-18,000
| -90% | -$4.63M |
|
3673
ReposiTrak
TRAK
$158M
| $522K | ﹤0.01% |
26,545
+7,905
| +42% | +$166K |
|
3674
First Western Financial
MYFW
$309M
| $518K | ﹤0.01% |
22,957
+5,493
| +31% | +$113K |
|
3675
Maravai LifeSciences
MRVI
$861M
| $518K | ﹤0.01% |
214,885
+60,631
| +39% | +$127K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.